Ensign Peak Advisors’s Medifast MED Stock Holding History

Ensign Peak Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,560	Closed	-$277K	–	2041
2022 Q3	$277K	Sell	2,560 -760	-23%	-$109K	﹤0.01%	1747
2022 Q2	$599K	Hold	3,320	–	–	﹤0.01%	1372
2022 Q1	$567K	Hold	3,320	–	–	﹤0.01%	1495
2021 Q4	$695K	Sell	3,320 -6,980	-68%	-$1.44M	﹤0.01%	1470
2021 Q3	$1.98M	Hold	10,300	–	–	﹤0.01%	1133
2021 Q2	$2.92M	Hold	10,300	–	–	0.01%	903
2021 Q1	$2.18M	Hold	10,300	–	–	﹤0.01%	1069
2020 Q4	$2.02M	Hold	10,300	–	–	﹤0.01%	1063
2020 Q3	$1.69M	Hold	10,300	–	–	﹤0.01%	1059
2020 Q2	$1.43M	Hold	10,300	–	–	﹤0.01%	1138
2020 Q1	$644K	Hold	10,300	–	–	﹤0.01%	1317
2019 Q4	$1.13M	Buy	+10,300	New	+$997K	﹤0.01%	1285

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Ensign Peak Advisors's MED Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Medifast (MED) in Q4 2022, closing a stake of 2,560 shares — an estimated $277K sold.

Ensign Peak Advisors first reported a position in MED in Q4 2019 and held it in 12 quarters. The position peaked at $2.92M in Q2 2021. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

Ensign Peak Advisors reported no remaining Medifast position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 2,560 Medifast shares in Q4 2022, an estimated $277K.
Ensign Peak Advisors first reported a position in Medifast in Q4 2019 and held it in 12 quarters.
Ensign Peak Advisors's Medifast position peaked at $2.92M in Q2 2021.
277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.